Estimativas de analistas de Wall Street para Apyx Medical Corporation (APYX): preço alvo de consenso, recomendações de compra/manter/venda e previsões de receita, LPA e EBITDA para os próximos exercícios.
Consenso de analistas
| Compra forte | 0 |
| Compra | 8 |
| Manter | 1 |
| Venda | 0 |
| Venda forte | 0 |
| Analistas no total | 9 |
| Avaliação média (1-5) | 0.89 |
Surpresas de Resultados Recentes
| Data | LPA Real | LPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.07 | ||
| 2026-08-06 | $-0.07 | $-0.08 | +14.6% |
| 2026-05-07 | $-0.05 | $-0.11 | +54.5% |
| 2026-03-10 | $-0.03 | $-0.06 | +50.0% |
| 2025-11-06 | $-0.05 | $-0.06 | +16.7% |
| 2025-08-07 | $-0.09 | $-0.09 | +3.6% |
| 2025-05-08 | $-0.10 | $-0.12 | +16.7% |
| 2025-03-13 | $-0.12 | $-0.13 | +7.7% |
Índices de avaliação
| Preço / Valor contábil | 11.90 |
| EV / EBITDA | -85.80 |
| Dividend Yield | 0.00% |
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receita | $36.6M | $38.9M | $16.7M | $28.2M | $27.7M | $48.5M | $44.5M | $52.3M | $48.1M | $52.8M |
| Custo da Receita | $18.7M | $19.1M | $5.9M | $9.1M | $10.2M | $14.9M | $15.4M | $18.6M | $18.7M | $33.8M |
| Lucro Bruto | $17.9M | $19.8M | $10.8M | $19.1M | $17.5M | $33.6M | $29.1M | $33.8M | $29.4M | $19.0M |
| P&D | $2.6M | $2.5M | $2.5M | $3.7M | $3.9M | $4.3M | $4.5M | $4.8M | $5.1M | $3.4M |
| Despesas Gerais e Administrativas | $19.1M | $21.0M | $21.2M | $36.2M | $33.7M | $43.7M | $48.1M | $48.9M | $43.1M | $36.1M |
| Despesas Operacionais | $21.7M | $23.5M | $23.7M | $40.0M | $37.6M | $48.0M | $52.7M | $51.0M | $48.2M | $25.5M |
| Lucro Operacional | -$3.8M | -$5.3M | -$13.6M | -$20.9M | -$20.1M | -$14.4M | -$23.6M | -$17.3M | -$18.8M | -$6.4M |
| EBITDA | -$3.8M | -$13.0M | -$13.9M | -$19.1M | -$18.5M | -$13.9M | -$22.0M | -$18.1M | -$16.8M | -$4.6M |
| Despesas com Juros | $158000 | $136000 | $104000 | $8000 | $46000 | $10000 | $15000 | $2.5M | $5.9M | $5.6M |
| Lucro Antes de Impostos | -$3.9M | -$5.2M | -$13.3M | -$19.8M | -$19.4M | -$14.8M | -$22.9M | -$21.3M | -$23.3M | -$10.8M |
| Imposto | $64000 | -$156000 | -$3.8M | -$130000 | -$7.5M | $380000 | $367000 | -$2.4M | $252000 | $270000 |
| Lucro Líquido | -$4.0M | -$5.1M | $64.0M | -$19.7M | -$11.9M | -$15.2M | -$23.2M | -$18.7M | -$23.5M | -$11.2M |
| LPA | $-0.14 | $-0.16 | $1.93 | $-0.58 | $-0.35 | $-0.44 | $-0.67 | $-0.54 | $-0.66 | $-0.27 |
| LPA Diluído | $-0.14 | $-0.16 | $1.86 | $-0.58 | $-0.35 | $-0.44 | $-0.67 | $-0.54 | $-0.66 | $-0.27 |
| Ações em Circulação (Diluídas) | $27.4M | $31.4M | $34.4M | $34.1M | $34.2M | $34.3M | $34.5M | $34.6M | $35.5M | $42.2M |
Preço
| Preço | $3.02 |
| Capitalização | $127M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ATOS · LUCD · NSPR · PDEX · QIPT · RCEL · RPID
Explorar setor: Healthcare · Medical - Specialties
Mais seções de APYX: Resumo · Financeiros · Avaliação · Estatísticas · Técnico · Propriedade · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações